Descripción
Baseline clinical characteristics and disease activity indices for children and adolescents enrolled in the sodium butyrate add-on therapy trial for newly diagnosed inflammatory bowel disease are presented.
Figure 1
Source Paper
Sodium Butyrate Effectiveness in Children and Adolescents with Newly Diagnosed Inflammatory Bowel Diseases-Randomized Placebo-Controlled Multicenter Trial.Cite This Figure
![Figure 1: Baseline clinical characteristics and disease activity indices for children and adolescents enrolled in the sodium butyrate add-on therapy trial for newly diagnosed inflammatory bowel disease are presented.]() > Source: Anna Pietrzak et al. "Sodium Butyrate Effectiveness in Children and Adolescents with Newly Diagnosed I." *Nutrients*, 2022. PMID: [36014789](https://pubmed.ncbi.nlm.nih.gov/36014789/)
<figure> <img src="" alt="Baseline clinical characteristics and disease activity indices for children and adolescents enrolled in the sodium butyrate add-on therapy trial for newly diagnosed inflammatory bowel disease are presented." /> <figcaption>Figure 1. Baseline clinical characteristics and disease activity indices for children and adolescents enrolled in the sodium butyrate add-on therapy trial for newly diagnosed inflammatory bowel disease are presented.<br> Source: Anna Pietrzak et al. "Sodium Butyrate Effectiveness in Children and Adolescents with Newly Diagnosed I." <em>Nutrients</em>, 2022. PMID: <a href="https://pubmed.ncbi.nlm.nih.gov/36014789/">36014789</a></figcaption> </figure>